Showing results (341-350 of 1,188) with videos related to

Sort By:
Pageof 119
Cancer|September 26, 2003
Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phaseHagop Kantarjian, Susan O'Brien, Jorges Cortes, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2009
Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest mediaMaiken Cavling Arendrup, Guillermo Garcia-Effron, Cornelia Lass-Flörl, et al.
Leukemia Research|July 16, 2003
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemiaApostolia Tsimberidou, Jorge Cortes, Deborah Thomas, et al.
Renal Failure|December 13, 2006
Cardiovascular risk factors in the Mexican populationGuillermo Garcia-Garcia, Raymundo Aviles-Gomez, Victor H Luquin-Arellano, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2010
Comparison of caspofungin MICs by means of EUCAST method EDef 7.1 using two different concentrations of glucoseJuan Luis Rodriguez-Tudela, Alicia Gomez-Lopez, Maiken C Arendrup, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Phase I and pharmacokinetic study of DX-8951f (exatecan mesylate), a hexacyclic camptothecin, on a daily-times-five schedule in patients with advanced leukemiaFrancis J Giles, Jorge E Cortes, Deborah A Thomas, et al.
Mycopathologia|September 30, 2016
Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in ArgentinaSoraya Eugenia Morales-López, Constanza G Taverna, María Eugenia Bosco-Borgeat, et al.
Leukemia & Lymphoma|May 25, 2019
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapyPrajwal Boddu, Preetesh Jain, Gautam Borthakur, et al.
Cancer|December 18, 2008
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimensDushyant Verma, Susan O'Brien, Deborah Thomas, et al.
Malaria Journal|January 17, 2019
Molecular monitoring of the diversity of human pathogenic malaria species in blood donations on Bioko Island, Equatorial GuineaTobias Schindler, Tamy Robaina, Julian Sax, et al.
Pageof 119